Filter
202
Filtered Results: 202
Text search:
counterfeit
drug
Featured
Recommendations
13
New Publications
65
Language
Document type
No document type
106
Studies & Reports
42
Guidelines
30
Manuals
9
Strategic & Response Plan
7
Situation Updates
3
Fact sheets
3
Training Material
2
Countries / Regions
Kenya
12
Uganda
11
Nigeria
7
Ethiopia
7
Ghana
7
Tanzania
6
Liberia
5
Zimbabwe
5
Cambodia
5
Sierra Leone
4
Zambia
4
Malawi
4
Botswana
4
Myanmar / Burma
4
Rwanda
3
South Africa
3
Bangladesh
3
Eswatini/ Swaziland
3
South–East Asia Region
3
Global
3
Senegal
2
Cameroon
2
Philippines
2
Nepal
2
Namibia
2
Ukraine
2
Africa
2
Burkina Faso
1
Congo, Democratic Republic of
1
Haiti
1
India
1
Somalia
1
Pakistan
1
Thailand
1
China
1
Indonesia
1
Mozambique
1
Central African Republic
1
Lesotho
1
Sri Lanka
1
Asia
1
Laos
1
Moldova
1
Vietnam
1
Authors & Publishers
Publication Years
Category
Countries
101
Public Health
12
Clinical Guidelines
9
Pharmacy & Technologies
6
Women & Child Health
2
Key Resources
2
Toolboxes
Pharmacy
35
AMR
32
Mental Health
6
TB
5
HIV
4
Global Health Education
4
Conflict
3
Rapid Response
3
COVID-19
3
Caregiver
2
Planetary Health
2
Disability
1
Ebola
1
Natural Hazards
1
Specific Hazards
1
Social Ethics
1
NCDs
1
Guide for coordinators and data collectors - The WHO Operational Package for Assessing, Monitoring and Evaluating Country Pharmaceutical Situations is intended as a useful tool for researchers, policy-makers, planners and others who need to use standardized measurement tools to gather data and other...
WHO Pharmacovigilance indicators: a practical manual for the assessment of pharmacovigilance systems
This manual provides a practical method for determining the pharmacovigilance indices. It is designed to be simple and can be understood by any worker in pharmacovigilance without formal training in monitoring and evaluation. Pharmacovigilance as a medical discipline is crucial in preventing medicin...
WHO Technical Report Series, No. 961, 2011, Annex 8 - These guidelines are intended to provide a description of ways in which pharmacists can improve access to health care, health promotion and the use of medicines on behalf of the patients they serve. The role of FIP is to provide leadership for na...
Economic Issues, Policies and Option for Action
Towards a Healthier Botswana
NHSP 2017- 2022 (Final draft)
The main objectives of these guidelines are to:
1. contribute to the quality assurance of medicinal plant materials used as the source for herbal medicines to improve the quality, safety and efficacy of finished herbal products; 2. guide the formulation of national and/or regional GACP guideli...
1. contribute to the quality assurance of medicinal plant materials used as the source for herbal medicines to improve the quality, safety and efficacy of finished herbal products; 2. guide the formulation of national and/or regional GACP guideli...
Recent efforts to fight malaria in the Greater Mekong Subregion (GMS) have yielded impressive results. According to the latest WHO estimates, the six GMS countries cut their malaria case incidence by an estimated 54% between 2012 and 2015. Malaria death rates fell by 84% over the same period.
I...
I...
The report explores strategies for sustaining the country’s responses to the three diseases and eventually transitioning away from external funding and programmatic support. It takes stock of Kenya’s health financing landscape and identifies opportunities and challenges for sustaining effective ...
Attention-Deficit/Hyperactivity Disorder
